Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.12B
| $194M | 0.14% |
4,226,078
-61,668
| -1% | -$2.85M |
|
102
Pinduoduo
PDD
$128B
| $193M | 0.14% |
3,126,544
-209,620
| -6% | -$9.82M |
|
103
Alcoa
AA
$11.8B
| $185M | 0.13% |
4,062,419
-177,185
| -4% | -$11.5M |
|
104
Mercado Libre
MELI
$96.3B
| $183M | 0.13% |
286,868
-7,373
| -3% | -$6.43M |
|
105
Southern Copper
SCCO
$146B
| $178M | 0.13% |
3,862,704
-227,954
| -6% | -$13.2M |
|
106
Norfolk Southern
NSC
$75.6B
| $171M | 0.12% |
751,949
+16,565
| +2% | +$4.07M |
|
107
Cleveland-Cliffs
CLF
$6.4B
| $167M | 0.12% |
10,864,657
-199,131
| -2% | -$4.76M |
|
108
Halliburton
HAL
$26.6B
| $167M | 0.12% |
5,315,424
+367,120
| +7% | +$13.7M |
|
|
GTLS
109
DELISTED
Chart Industries
GTLS
| $162M | 0.12% |
970,450
-23,255
| -2% | -$3.97M |
|
110
ExxonMobil
XOM
$643B
| $162M | 0.11% |
1,896,532
-47,662
| -2% | -$4.3M |
|
111
Globant
GLOB
$1.6B
| $162M | 0.11% |
931,600
-20,483
| -2% | -$4.17M |
|
112
Deere & Co
DE
$163B
| $162M | 0.11% |
539,755
+168,428
| +45% | +$62M |
|
113
Vanguard FTSE Developed Markets ETF
VEA
$230B
| $155M | 0.11% |
3,811,235
+252,374
| +7% | +$11.2M |
|
114
NetEase
NTES
$84.2B
| $155M | 0.11% |
1,659,397
-59,799
| -3% | -$5.69M |
|
115
Autodesk
ADSK
$49.6B
| $153M | 0.11% |
888,762
+43,005
| +5% | +$8.27M |
|
116
Domino's
DPZ
$12.1B
| $142M | 0.1% |
363,469
+4,827
| +1% | +$1.79M |
|
117
iShares Global Energy ETF
IXC
$2.83B
| $140M | 0.1% |
4,123,653
+371,551
| +10% | +$13.9M |
|
118
Align Technology
ALGN
$12.4B
| $138M | 0.1% |
583,361
+12,318
| +2% | +$3.78M |
|
119
NXP Semiconductors
NXPI
$56.5B
| $137M | 0.1% |
925,679
+1,824
| +0.2% | +$317K |
|
120
Boston Scientific
BSX
$72B
| $134M | 0.1% |
3,605,311
+100,331
| +3% | +$4.08M |
|
121
Procter & Gamble
PG
$338B
| $134M | 0.09% |
930,273
+16,776
| +2% | +$2.52M |
|
122
Woodside Energy
WDS
$43.1B
| $133M | 0.09% |
+6,156,348
| New | +$140M |
|
123
ASE Group
ASX
$80.7B
| $130M | 0.09% |
25,148,290
-537,393
| -2% | -$3.58M |
|
124
Pfizer
PFE
$143B
| $129M | 0.09% |
2,460,472
-12,419
| -0.5% | -$633K |
|
125
Synaptics
SYNA
$4.13B
| $125M | 0.09% |
1,055,577
-16,990
| -2% | -$2.49M |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.